Biotech on the Rise: Heidelberg’s Leap Into the Future of Science

Renowned institutions like the German Cancer Research Center (DKFZ), the EMBL, and Heidelberg University are collaborating closely with industry partners to drive innovation in cell and gene therapies, synthetic immunology, and personalized medicine.

Initiatives such as the Health + Life Science Alliance Innovation Campus, the beLAB2122 program, and the BioRN cluster demonstrate Heidelberg’s ambition to become a key player in the future of science and global biotech innovation.

Source:
Original report by RNF: “Biotech on the Rise – Why Heidelberg is Becoming a Showcase for the Science of the Future” – available at www.rnf.de